Top Markets
Coin of the day
Stratec SE Stratec SE

Stratec SE

SBS
Rang in Aktien #15320
Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE... Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE (previously known as STRATEC Biomedical AG until its name change in December 2018) specializes in the development and manufacturing of cutting-edge automation and instrumentation systems. The company caters to the in-vitro diagnostics and life sciences sectors, operating across Germany, the European Union, and globally. Its business is divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on designing and fabricating automated analytical systems, along with necessary spare parts and supplies, for customers in clinical diagnostics and biotechnology. The Diatron segment provides a suite of systems, components, disposables, and assays for lower-volume hematology and clinical chemistry applications. Finally, the Smart Consumables segment is dedicated to engineering and producing intelligent consumables for the diagnostics, life sciences, and medical technology industries.
Aktienkurs
$29.59
Marktkapitalisierung
$359.75M
Veränderung (1 Tag)
-1.58%
Veränderung (1 Jahr)
-4.28%
Land
DE
Handel Stratec SE (SBS)

Kategorie

Dividendenrendite-Verlauf für Stratec SE (SBS)
Dividendenrendite (TTM) von Stratec SE (Aktienkürzel: SBS) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Stratec SE (SBS) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber